Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia.

PubWeight™: 0.81^‹?›

🔗 View Article (PMID 27059354)

Published in Clin Infect Dis on May 01, 2016

Authors

Evans M Mpabalwani¹, Chibumbya J Simwaka², Jason M Mwenda³, Cynthia P Mubanga², Mwaka Monze², Belem Matapo⁴, Umesh D Parashar⁵, Jacqueline E Tate⁵

Author Affiliations

1: Department of Paediatrics and Child Health.
2: Virology Laboratory, University Teaching Hospital, Lusaka, Zambia.
3: World Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
4: World Health Organization Country Office, Lusaka, Zambia.
5: Centers for Disease Control and Prevention, Atlanta, Georgia.

Associated clinical trials:

Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia (ROTAVAC) | NCT03602053

Articles citing this ↘

Rotavirus vaccines: current global impact and future perspectives. Future Virol (2016) 0.75

Reduction in Diarrhea- and Rotavirus-related Healthcare Visits among Children <5 Years of Age Following National Rotavirus Vaccine Introduction in Zimbabwe. Pediatr Infect Dis J (2017) 0.75

Articles by these authors ⇆

Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. Clin Infect Dis (2016) 1.36

The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda. PLoS One (2016) 0.79

Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda. Clin Infect Dis (2016) 0.79

Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies. Clin Infect Dis (2016) 0.77

Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016. Clin Infect Dis (2017) 0.76

Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. J Infect Dis (2016) 0.75